Abstract

Pharmacogenomics as a Competitive Strategy for Compounding Pharmacies

Author(s): Maham Nicole Y

Issue: Nov/Dec 2022 - Volume 26, Number 6

Page(s): 474-479

Download in electronic PDF format for $75
  • Pharmacogenomics as a Competitive Strategy for Compounding Pharmacies Page 1
  • Pharmacogenomics as a Competitive Strategy for Compounding Pharmacies Page 2
  • Pharmacogenomics as a Competitive Strategy for Compounding Pharmacies Page 3
  • Pharmacogenomics as a Competitive Strategy for Compounding Pharmacies Page 4
  • Pharmacogenomics as a Competitive Strategy for Compounding Pharmacies Page 5
  • Pharmacogenomics as a Competitive Strategy for Compounding Pharmacies Page 6

Abstract

Patients’ responses to medical treatment vary greatly; while many may benefit from pharmacological therapy, others may suffer from harmful drug reactions or show no response at all. To provide an effective individualized care, one must understand the elements that lead to varying patient outcomes and how these factors may interplay in an individual’s treatment outcome. Pharmacogenomics is the future of pharmacy, and there is a growing demand for this service. Compounding pharmacies are already at the forefront of meeting patients’ unique drug requirements. This gives them the opportunity to provide their patients with more valuable services than only selling drugs dictated by the formula! This article discusses pharmacogenomics as a competitive strategy for compounding pharmacies.

Related Keywords

  • treatment outcomes
  • pharmacogenomics
  • drug response
  • personalized medicine
  • pharmacokinetics
  • pharmacodynamics
  • genetic polymorphism
  • genome-wide association studies
  • single-nucleotide polymorphisms
  • copy number variations
  • Clinical Pharmacogenomics Implementation Consortium
  • CPIC
  • gene-drug pairings
  • metabolizer phenotypes
  • pharmacogenomics implementation models
  • pharmacogenomic counseling
  • genetic counselors

Related Categories

  • BUSINESS
  • MARKETING
  • TECHNOLOGY
  • PATIENT ASSESSMENT
  • PROFESSIONAL ISSUES

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2022
Pg. 474-479
Pharmacogenomics as a Competitive Strategy for Compounding Pharmacies
Author(s): Maham Nicole Y
Jul/Aug 2015
Pg. 280-287
Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 2
Author(s): Allen Loyd V
Mar/Apr 2018
Pg. 95-107
Pharmacogenomics: Precision Pharmacy in 503A Compounding
Author(s): Drummond Joseph, Bennet Daron, Allen Loyd V Jr
Jan/Feb 2007
Pg. 59-65
Pharmacogenomics: The End of Trial-and-Error Medicine?
Author(s): Vail Jane
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Mar/Apr 2017
Pg. 95-102
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies
Author(s): Yoch Doug
Mar/Apr 2018
Pg. 108-121
Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management
Author(s): Soni Abhishek, Gowthamarajan Kuppusamy, Radhakrishnan Arun
Jul/Aug 2005
Pg. 303-306
Basics of Pharmacogenomics for the Compounding Pharmacist
Author(s): Kupiec Thomas C, Raj Vishnu
Jul/Aug 2003
Pg. 266-270
Sensitization Therapy for Warts
Author(s): Kuntz Rachael
Jul/Aug 2003
Pg. 288-291
Basics of Compounding for Raynaud's Disease
Author(s): Glasnapp Andrew
Nov/Dec 2013
Pg. 452-457
Clinical Utility of Pharmacogenetic Testing in Compounding Pharmacy
Author(s): Fichter Brian, Heintzelman Tom, Hurst Sawan, Fitzsimmons Dorothy, Mailloux Christina
Nov/Dec 2018
Pg. 471-473
Compounding from a Pharmacy Student's Perspective: Staying Competitive as a Compounding Pharmacy
Author(s): Waldschmidt Ryan
Sep/Oct 2020
Pg. 356
Safety and Efficacy Studies, Pharmacy Education, and the NASEM Report on Compounded Topical Pain Creams
Author(s): Allen Loyd V Jr
Sep/Oct 2010
Pg. 366-369
Community Pharmacy Addresses the Need for Proper Drug Disposal with Positive Response
Author(s): Briggs Valerie
Jan/Feb 2015
Pg. 38-40
Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 1
Author(s): Allen Loyd V Jr
Nov/Dec 2003
Pg. 441-447
Single-Patient Trials, Extemporaneously Compounded Products and Pharmaceutical Care
Author(s): Fassett William E
Sep/Oct 2022
Pg. 411-418
Sterile Basics of Compounding: Contamination Control Strategies, Part 1
Author(s): Summers Amy
Jan/Feb 2018
Pg. 7-16
Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies
Author(s): Pritchett Jon, McCrory Gary, Kraemer Cheri, Jensen Brenda, Allen Loyd V Jr
Sep/Oct 2016
Pg. 367-374
Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy
Author(s): Kochanowska-Karamyan Anna J
Nov/Dec 2015
Pg. 453-463
Applying Quality of Design Concepts to Pharmacy Compounding
Author(s): Timko Robert J